series-c-plus
Stage
2005
Founded
3
Investors
About
A clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases.
Explore Erytech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.